NCT00007891View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1997

Study Completion Date

October 31, 2004

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

indium In 111 monoclonal antibody BrE-3

RADIATION

yttrium Y 90 monoclonal antibody BrE-3

Trial Locations (2)

80010

University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora

94107

Cancer Research Institute of Contra Costa, San Francisco

All Listed Sponsors
lead

Cancer Research Institute of Contra Costa

OTHER

NCT00007891 - Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter